Literature DB >> 29461981

CYP3A4 mutation causes vitamin D-dependent rickets type 3.

Jeffrey D Roizen1, Dong Li2, Lauren O'Lear1, Muhammad K Javaid3, Nicholas J Shaw4, Peter R Ebeling5, Hanh H Nguyen5, Christine P Rodda6, Kenneth E Thummel7, Tom D Thacher8, Hakon Hakonarson2, Michael A Levine1.   

Abstract

Genetic forms of vitamin D-dependent rickets (VDDRs) are due to mutations impairing activation of vitamin D or decreasing vitamin D receptor responsiveness. Here we describe two unrelated patients with early-onset rickets, reduced serum levels of the vitamin D metabolites 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and deficient responsiveness to parent and activated forms of vitamin D. Neither patient had a mutation in any genes known to cause VDDR; however, using whole exome sequencing analysis, we identified a recurrent de novo missense mutation, c.902T>C (p.I301T), in CYP3A4 in both subjects that alters the conformation of substrate recognition site 4 (SRS-4). In vitro, the mutant CYP3A4 oxidized 1,25-dihydroxyvitamin D with 10-fold greater activity than WT CYP3A4 and 2-fold greater activity than CYP24A1, the principal inactivator of vitamin D metabolites. As CYP3A4 mutations have not previously been linked to rickets, these findings provide insight into vitamin D metabolism and demonstrate that accelerated inactivation of vitamin D metabolites represents a mechanism for vitamin D deficiency.

Entities:  

Keywords:  Bone Biology; Bone disease; Genetic diseases; Genetics

Mesh:

Substances:

Year:  2018        PMID: 29461981      PMCID: PMC5919884          DOI: 10.1172/JCI98680

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Target cell metabolism of 1,25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation.

Authors:  G Makin; D Lohnes; V Byford; R Ray; G Jones
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets.

Authors:  S Kitanaka; K Takeyama; A Murayama; T Sato; K Okumura; M Nogami; Y Hasegawa; H Niimi; J Yanagisawa; T Tanaka; S Kato
Journal:  N Engl J Med       Date:  1998-03-05       Impact factor: 91.245

3.  Effects of a commonly occurring genetic polymorphism of human CYP3A4 (I118V) on the metabolism of anandamide.

Authors:  Matthew Pratt-Hyatt; Haoming Zhang; Natasha T Snider; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2010-08-11       Impact factor: 3.922

4.  Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24.

Authors:  T Sakaki; N Sawada; K Komai; S Shiozawa; S Yamada; K Yamamoto; Y Ohyama; K Inouye
Journal:  Eur J Biochem       Date:  2000-10

5.  Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance.

Authors:  Hong Chen; Martin Hewison; Bing Hu; John S Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

6.  Vitamin D3--resistant fibroblasts have immunoassayable 1,25-dihydroxyvitamin D3 receptors.

Authors:  J W Pike; S Dokoh; M R Haussler; U A Liberman; S J Marx; C Eil
Journal:  Science       Date:  1984-05-25       Impact factor: 47.728

7.  Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization.

Authors:  Dong Li; Evan E Opas; Florin Tuluc; Daniel L Metzger; Cuiping Hou; Hakon Hakonarson; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2014-05-13       Impact factor: 5.958

8.  The CYP3A4*18 genotype in the cytochrome P450 3A4 gene, a rapid metabolizer of sex steroids, is associated with low bone mineral density.

Authors:  Y S Kang; S Y Park; C H Yim; H S Kwak; P Gajendrarao; N Krishnamoorthy; S-C Yun; K W Lee; K O Han
Journal:  Clin Pharmacol Ther       Date:  2008-11-19       Impact factor: 6.875

9.  CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis.

Authors:  Ram P Gupta; You Ai He; Kennerly S Patrick; James R Halpert; Norman H Bell
Journal:  J Clin Endocrinol Metab       Date:  2004-11-16       Impact factor: 5.958

10.  Comparison of two endogenous biomarkers of CYP3A4 activity in a drug-drug interaction study between midostaurin and rifampicin.

Authors:  Catherine Dutreix; Sebastien Lorenzo; Yanfeng Wang
Journal:  Eur J Clin Pharmacol       Date:  2014-05-21       Impact factor: 2.953

View more
  27 in total

Review 1.  New developments in our understanding of vitamin metabolism, action and treatment.

Authors:  Sylvia Christakos; Shanshan Li; Jessica De La Cruz; Daniel D Bikle
Journal:  Metabolism       Date:  2019-06-19       Impact factor: 8.694

Review 2.  Using stable isotope tracers to study bone metabolism in children.

Authors:  Kimberly O O'Brien; Steven A Abrams
Journal:  J Physiol       Date:  2018-07-17       Impact factor: 5.182

3.  The good and the bad of vitamin D inactivation.

Authors:  Marie B Demay
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

Review 4.  Genetic variants of mineral metabolism in health and disease.

Authors:  Cassianne Robinson-Cohen
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-07       Impact factor: 2.894

Review 5.  Vitamin D Metabolism and Guidelines for Vitamin D Supplementation.

Authors:  Indra Ramasamy
Journal:  Clin Biochem Rev       Date:  2020-12

Review 6.  The Causes of Hypo- and Hyperphosphatemia in Humans.

Authors:  Eugénie Koumakis; Catherine Cormier; Christian Roux; Karine Briot
Journal:  Calcif Tissue Int       Date:  2020-04-13       Impact factor: 4.333

Review 7.  Is calcifediol better than cholecalciferol for vitamin D supplementation?

Authors:  J M Quesada-Gomez; R Bouillon
Journal:  Osteoporos Int       Date:  2018-04-30       Impact factor: 4.507

8.  Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders.

Authors:  Thomas J Weber; L Darryl Quarles
Journal:  Curr Mol Biol Rep       Date:  2019-02-09

Review 9.  Vitamin D Metabolism Revised: Fall of Dogmas.

Authors:  Roger Bouillon; Dan Bikle
Journal:  J Bone Miner Res       Date:  2019-10-29       Impact factor: 6.741

10.  Vitamin D Therapy and the Era of Precision Medicine.

Authors:  Jeffrey D Roizen; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.